Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?
about
Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss.Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue.Chicoric acid is a potent anti-atherosclerotic ingredient by anti-oxidant action and anti-inflammation capacity.Lipid peroxidation generates body odor component trans-2-nonenal covalently bound to protein in vivoLOX-1 in atherosclerosis: biological functions and pharmacological modifiers.3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients.Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligandRole of six single nucleotide polymorphisms, risk factors in coronary disease, in OLR1 alternative splicingGenetic variability and the risk of myocardial infarction in Poles under 45 years of age.Genetic variants of the class A scavenger receptor gene are associated with essential hypertension in Chinese.Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI).6-Shogaol Protects against Oxidized LDL-Induced Endothelial Injruries by Inhibiting Oxidized LDL-Evoked LOX-1 SignalingCryptotanshinone inhibits TNF-α-induced LOX-1 expression by suppressing reactive oxygen species (ROS) formation in endothelial cells.The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.Dihydrotanshinone I Attenuates Atherosclerosis in ApoE-Deficient Mice: Role of NOX4/NF-κB Mediated Lectin-Like Oxidized LDL Receptor-1 (LOX-1) of the Endothelium.LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production.CRP is a novel ligand for the oxidized LDL receptor LOX-1.Exercise intervention attenuates hyperhomocysteinemia-induced aortic endothelial oxidative injury by regulating SIRT1 through mitigating NADPH oxidase/LOX-1 signaling.Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo.Oligomerization is required for the activity of recombinant soluble LOX-1.EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling.Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.Exposure to traffic-generated air pollutants mediates alterations in brain microvascular integrity in wildtype mice on a high-fat diet.Ginkgo biloba extract attenuates oxLDL-induced oxidative functional damages in endothelial cells.Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.
P2860
Q33585814-B3010003-9D93-4930-A0E2-C11543C2BC04Q33638451-BB4028CE-70E2-4BC6-8D6B-9B655A448202Q33728074-3D0AEC67-993D-474F-9E13-1DB15F87C034Q33832490-0C243798-4146-4046-BD6E-22815DF3F8FAQ34079451-D6F00287-CF5E-4413-B35A-0A226F5E298AQ34440283-63F7F110-0E06-4511-BDA7-5BFED713CC4BQ35011105-C272245A-3BA1-4D41-A269-EAA6598FE54BQ35621461-58FE2957-4640-4D2F-969C-0158CFEF16BDQ35762003-7FC5E5EF-645D-4C5F-9CC8-E0A8EFF5A29BQ36345702-7BCCCE5B-1BC3-4DD0-91C4-DB66DA21D8D4Q36493187-1C6083D8-1DA0-4B63-BDD6-0D834C2B9ED9Q36663149-115948EB-A402-428B-8345-E3F51FF4DF0BQ37060279-0487951E-225B-42A7-89B1-3B2E7C0608FFQ37122696-C7ACDF8F-941A-41B2-8C75-62E1EBDDB2C6Q37408943-E39CA7F6-791E-4534-ADA4-538FC5C89A61Q38355976-4EE46548-1FCF-4D18-9E64-8423D209402AQ39735483-9546E0DA-2F31-434E-A744-CEB83EDF99F1Q39878373-DBF2D44C-9117-4A98-811C-0D95D963BF55Q41183823-9D3394AE-83AF-4E5D-9B07-EF24E4F630B9Q41933923-0F26389C-9FFB-45FF-8CF3-964A7C76FCF5Q42152313-5469EA1C-AC54-4B1D-BCD9-FDB3F309C385Q43142712-30354098-BE3E-448B-9BE7-0D56312C2F52Q46363692-D33DC1F4-9EDA-41B6-93C4-A8D8DB08A605Q47407286-1AFDD92B-BF21-40D4-935A-3293C2AF7B10Q51811887-2DC9E5F8-2E05-4F47-91DD-345D79E65DD4Q52149033-C17F01A5-84F2-4F4F-A71D-6427CD4077E1Q54632828-1DCCA93A-7FA8-453D-8A61-70FE5A134CA9
P2860
Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Lectin-like oxidized low-densi ...... he therapy of atherosclerosis?
@en
type
label
Lectin-like oxidized low-densi ...... he therapy of atherosclerosis?
@en
prefLabel
Lectin-like oxidized low-densi ...... he therapy of atherosclerosis?
@en
P2093
P2860
P1476
Lectin-like oxidized low-densi ...... he therapy of atherosclerosis?
@en
P2093
Guan-Hua Du
Tian-Tai Zhang
Xiu-Ping Chen
P2860
P304
P356
10.1111/J.1527-3466.2007.00009.X
P577
2007-01-01T00:00:00Z